MedTrace Logo

Renal Denervation in Patients With Chronic Heart Failure With Preserved Ejection Fraction

NCT05715697 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-02-01

No results posted yet for this study

Summary

This study aims to explore the potential of RDN as a therapy for HFpEF in a Prospective, Multicenter, Randomized, Blinded, Sham-controlled Study.

Conditions

Interventions

PROCEDURE

Sham procedure and maintenance of heart failure medications

Sham intervention, maintenance of heart failure medications

PROCEDURE

Renal denervation and maintenance of heart failure medications

Renal denervation and maintenance of heart failure medications

Sponsors & Collaborators

  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER

  • Xinjiang Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-09-01
Completion
2026-09-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05715697 on ClinicalTrials.gov